ACGL

Arch is a high-quality, diversified specialty P&C and mortgage insurer that the market is pricing like a no-growth value trap at 7.9x FY2025 diluted EPS of $11.60 and 1.6x sales. The fundamentals don't support that discount: FY2025 revenue grew 14.3% to $19.9B, net income of $4.40B held an excellent 22.1% net margin and 18.2% ROE, and management reported a 20.1% net income return on average common equity with 22.6% book-value-per-share growth. The balance sheet is pristine — debt is only 10.1% of total capital, shareholders' equity grew 16.3% to $24.2B, and retained earnings climbed 19.2% to $27.0B. This is a capital-generating machine: it bought back $1.9B of stock in 2025 (shares out down 5.2%), shrinking the share count while equity compounds.

The bearish nuance is real and visible in the filing. Net income growth has flattened (+2.0% in FY2025, EPS +3.7%) after the 2023 surge, and management explicitly frames 2026 with 'measured optimism and increased competition across our property and casualty businesses' — code for a softening underwriting cycle where premium rates and underwriting margins compress. The mortgage segment is also a watch item: the PMIERs sufficiency ratio slipped from 186% to 179%, and on a fully-phased-in basis (GSE investment-risk deduction through September 2026) drops to a pro-forma 173%. Still comfortably above the 100% requirement, but the trend is down.